|
⚲
|
| Keyboard |
| Section 32 Fund 1 LP
✚
|
|
|---|---|
| CIK # | 0001691436 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001691436] | |
| 4 | [0001691436] | |
| D | [0001691436] | |
| SC 13D | [0001691436] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Section 32 Fund 1 LP | Dave Inc | [2022-01-14] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Maris William J | |
| Section 32 GP 1 LLC | |
| Section 32 Fund 1 LP | |
| Dave Inc/DE | |
| X4 Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Dave Inc/DE DAVE
Class A Common Stock
|
2024-10-09 | Sell | 1,000,000 | $40.60 | 40,600,000 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2024-05-10 | Sell | 110,000 | $48.90 | 5,379,000 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2024-05-07 | Sell | 450,000 | $48.90 | 22,005,000 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2023-08-08 | Sell | 297,771 | $5.73 | 1,706,228 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-09-30 | Sell | 97,300 | $0.36 | 35,028 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-09-29 | Sell | 400,974 | $0.35 | 140,341 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-09-28 | Sell | 248,782 | $0.42 | 104,488 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-09-27 | Sell | 98,364 | $0.44 | 43,280 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-09-15 | Sell | 24,181 | $0.50 | 12,090 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-09-13 | Sell | 18,181 | $0.51 | 9,272 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-09-12 | Sell | 65,133 | $0.53 | 34,520 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-08-15 | Sell | 2,094,168 | $0.61 | 1,277,442 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-08-12 | Sell | 656,654 | $0.66 | 433,392 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-08-10 | Sell | 361,633 | $0.74 | 267,608 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-08-09 | Sell | 1,380,045 | $0.76 | 1,048,834 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-08-08 | Sell | 317,404 | $0.77 | 244,401 |
|
Dave Inc/DE DAVE
Class A Common Stock
|
2022-01-05 | Grant | 98,114,926 | ||
|
X4 Pharmaceuticals Inc ASNS
Series D Convertible Preferred Stock · derivative
|
2017-11-20 | Conversion | 1,540,500 | $0.00 | |
|
X4 Pharmaceuticals Inc ASNS
Common Stock
|
2017-11-20 | Conversion | 451,362 |